# EDGAR Filing Document

**Accession Number:** 0000883107
**File Stem:** 0001999371-25-012350
**Filing Date:** 2025-8
**Character Count:** 6185
**Document Hash:** 49317b311a9e4cc8cef4b6eb24282a9d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-25-012350.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001999371-25-012350

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250828

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250829

**DATE AS OF CHANGE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SOLESENCE, INC.
- **CENTRAL INDEX KEY:** 0000883107
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 363687863
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42589
- **FILM NUMBER:** 251281971

**BUSINESS ADDRESS:**
- **STREET 1:** 1319 MARQUETTE DRIVE
- **CITY:** ROMEOVILLE
- **STATE:** IL
- **ZIP:** 60446
- **BUSINESS PHONE:** 6307716078

**MAIL ADDRESS:**
- **STREET 1:** 1319 MARQUETTE DRIVE
- **CITY:** ROMEOVILLE
- **STATE:** IL
- **ZIP:** 60446

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NANOPHASE TECHNOLOGIES Corp
- **DATE OF NAME CHANGE:** 20160208

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NANOPHASE TECHNOLOGIES CORPORATION
- **DATE OF NAME CHANGE:** 19970305

?xml version='1.0' encoding='ASCII'? Current Report

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

 **CURRENT REPORT**

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 28, 2025

**SOLÉSENCE, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **0-22333** | **36-3687863** |
| (State or other | (Commission | (IRS Employer |
| jurisdiction of | File Number) | Identification No.) |
| incorporation) |  |  |

---

**1319 Marquette Drive**

**Romeoville, Illinois 60446**

(Address of Principal Executive Offices) (Zip Code)

**(630) 771-6708**

(Registrant's telephone number, including area code)

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value per share | SLSN | The NASDAQ Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.07. Submission of Matters to a Vote of Security Holders.**

On August 28, 2025, Solésence, Inc. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting"). As of July 21, 2025, the record date for holders of shares of common stock (the "Shares") entitled to vote at the Annual Meeting, there were 70,481,945 Shares outstanding and entitled to vote at the Annual Meeting. Of the Shares entitled to vote, 61,205,907, or approximately 86.83% of the Shares, were present or represented by proxy at the Annual Meeting, constituting a quorum under the Company's Certificate of Incorporation. There were three matters presented and voted on at the Annual Meeting. Set forth below is a brief description of each matter voted on at the Annual Meeting and the final voting results with respect to each such matter.

**Proposal 1 – Election of two director nominees.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Nominee** | &nbsp;&nbsp;**Votes For** | &nbsp;&nbsp;**Votes Against** | &nbsp;&nbsp;**Withheld** | &nbsp;&nbsp;**Broker Non-Votes** |
| &nbsp;&nbsp;R. Janet Whitmore | &nbsp;&nbsp;55548531 | &nbsp;&nbsp;0 | &nbsp;&nbsp;1019946 | &nbsp;&nbsp;4637430 |
| &nbsp;&nbsp;Laura M. Beres | &nbsp;&nbsp;55853069 | &nbsp;&nbsp;0 | &nbsp;&nbsp; 715408 | &nbsp;&nbsp;4637430 |

---

The shareholders elected each of the nominees as directors.

**Proposal 2 – Approval of the Company's 2025 Equity Compensation Plan.**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Votes For** | &nbsp;&nbsp;**Votes Against** | &nbsp;&nbsp;**Abstentions** | &nbsp;&nbsp;**Broker Non-Votes** |
| &nbsp;&nbsp;Votes Cast | &nbsp;&nbsp;56,301,567 | &nbsp;&nbsp;207,542 | &nbsp;&nbsp;59,368 | &nbsp;&nbsp;4,637,430 |

---

The shareholders approved the Company's 2025 Equity Compensation Plan.

**Proposal 3 – Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for 2025.**

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Votes For** | &nbsp;&nbsp;**Votes Against** | &nbsp;&nbsp;**Abstentions** |
| &nbsp;&nbsp;Votes Cast | &nbsp;&nbsp;61,074,473 | &nbsp;&nbsp;122,447 | &nbsp;&nbsp;8,987 |

---

The shareholders ratified the appointment of RSM US LLP as the Company's independent registered public accounting firm for fiscal year 2025.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 28, 2025

SOLÉSENCE, INC.

By:

/s/ JESS JANKOWSKI

Name: Jess Jankowski

Title: Chief Executive Officer